Search results for "Biological product"

showing 10 items of 126 documents

Design, synthesis and stimuli responsive gelation of novel stigmasterol-amino acid conjugates.

2020

Abstract An efficient synthesis of three novel stigmasterol-amino acid (glycine, l -leucine and l -phenylalanine) conjugates as stimuli responsive gelators is reported. The gelation properties of the prepared compounds were investigated in a variety of organic as well as aqueous solvents. The most striking finding of our investigation was that the hydrochloride salts of the prepared conjugates acted as gelators, whereas the neutral conjugates were either non-gelators or formed only a weak gel in anisole. The hydrochloride salts of stigmasteryl glycinate and l -leucinate form gels in n-alcohols (n = 4–10) and in ethane-1,2-diol, and that of stigmasteryl l -phenylalaninate forms gels in aroma…

Magnetic Resonance SpectroscopyHydrochloridePhenylalanineGlycineStigmasterolPhenylalaninePhase TransitionBiomaterialschemistry.chemical_compoundColloid and Surface ChemistryLeucineSpectroscopy Fourier Transform InfraredOrganic chemistrychemistry.chemical_classificationBiological ProductsAqueous solutionChemistryWaterHydrogen BondingHydrogen-Ion ConcentrationAnisoleSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsAmino acidDelayed-Action PreparationsGlycineSelf-healing hydrogelsMicroscopy Electron ScanningSolventsHydrochloric AcidLeucineGelsJournal of colloid and interface science
researchProduct

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

2021

Background & Aims: The ANSWER study reported that long-term albumin administration in patients with cirrhosis and uncomplicated ascites improves survival. During treatment, serum albumin increased within a month and remained stable thereafter. In this post hoc analysis, we aimed to determine whether on-treatment serum albumin levels could guide therapy. Methods: Logistic regression was used to assess the association between baseline serum albumin and mortality, as well as to determine on-treatment factors associated with mortality and to predict the achievement of a given on-treatment serum albumin level. Survival was assessed by Kaplan-Meier estimates and second-order polynomial regres…

Male0301 basic medicineCirrhosisascites; complications; liver cirrhosis; serum albumin; survivalSerum albuminSurvival.Logistic regressionGastroenterologyBiomarkers PharmacologicalAscites; Cirrhosis; Complications; Serum albumin; Survivalascites0302 clinical medicineAscitesMedicinebiologyMiddle AgedIntention to Treat AnalysisTreatment OutcomeCirrhosisAsciteFemale030211 gastroenterology & hepatologyDrug Monitoringmedicine.symptommedicine.medical_specialtycomplicationsSettore MED/12 - GASTROENTEROLOGIAliver cirrhosisSerum albuminSerum Albumin Humansurvival03 medical and health sciencesSerum albumin levelPredictive Value of TestsInternal medicinePost-hoc analysisHumansIn patientBiological ProductsCirrhosiHepatologybusiness.industryAlbuminmedicine.diseaseLong-Term CareSurvival Analysis030104 developmental biologybiology.proteinbusinessComplication
researchProduct

Potential hepatoprotective effects of new Cuban natural products in rat hepatocytes culture.

2008

The protective effects of five Cuban natural products (Mangifera indica L. (MSBE), Erythroxylum minutifolium, Erythroxylum confusum, Thalassia testudinum and Dictyota pinnatifida extracts and mangiferin) on the oxidative damage induced by model toxicants in rat hepatocyte cultures were studied. Cells were pre-incubated with the natural products (5-200 microg/mL) for 24 h. Then hepatotoxins (tert-butyl hydroperoxide, ethanol, carbon tetrachloride and lipopolysaccharide) were individually added and post-incubated for another 24 h. After treatments, cell viability was determined using the MTT assay. Mangiferin and MSBE exhibited the highest cytoprotective potential (EC50 between 50 and 125 mic…

MaleAntioxidantCell Survivalmedicine.medical_treatmentTetrazolium SaltsToxicologyChemopreventionAntioxidantsXenobioticsLipid peroxidationRats Sprague-Dawleychemistry.chemical_compoundMalondialdehydemedicineAnimalsMangiferinCells CulturedEC50Biological ProductsFormazansTraditional medicinebiologyDose-Response Relationship DrugCubaGeneral MedicineGlutathionebiology.organism_classificationGlutathioneErythroxylumRatsOxidative StressHepatoprotectionchemistryBiochemistryCarbon tetrachlorideHepatocytesMedicine TraditionalChemical and Drug Induced Liver InjuryToxicology in vitro : an international journal published in association with BIBRA
researchProduct

Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease R…

2017

Introduction: There is a growing interest in nutraceuticals improving cardiovascular risk factor levels and related organ damage. Methods: This double-blind, placebo-controlled randomized clinical trial aims to compare the effect of a combined nutraceutical containing red yeast rice (10 mg), phytosterols (800 mg), and l-tyrosol (5 mg) on lipid profile, blood pressure, endothelial function, and arterial stiffness in a group of 60 patients with polygenic hypercholesterolemia resistant to Mediterranean diet. Results: After 8 weeks of treatment, when compared to the placebo group, the active treated patients experienced a more favorable percentage change in total cholesterol (−16.3% vs 9.9…

MaleBlood Pressure030204 cardiovascular system & hematologyGastroenterologychemistry.chemical_compoundDietary supplement0302 clinical medicineRisk FactorsPhytosterolPharmacology (medical)030212 general & internal medicineEndothelial dysfunctionOriginal ResearchFramingham Risk Scoremedicine.diagnostic_testAnticholesteremic AgentsFatty liverPhytosterolsGeneral MedicineMiddle AgedDietary supplementsCholesterolBiochemistryCardiovascular DiseasesFemaleNutraceuticalsNutraceuticalAdultmedicine.medical_specialtyl-TyrosolHypercholesterolemiaPlacebo03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansRisk factorBiological ProductsCholesterolbusiness.industryHemodynamicsmedicine.diseaseCardiovascular disease riskBlood pressurechemistryRed yeast riceArterial stiffnessLipid profilebusinessBiomarkers
researchProduct

Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study

2020

Data are relatively scarce on gastro-intestinal tuberculosis (GITB). Most studies are old and from single centers, or did not include immunosuppressed patients. Thus, we aimed to determine the clinical, radiological, and laboratory profiles of GITB. We included adults with proven GITB treated between 2000 and 2018. Patients were enrolled from 21 referral centers in 8 countries (Belgium, Egypt, France, Italy, Kazakhstan, Saudi Arabia, UK, and Turkey). One hundred four patients were included. Terminal ileum (n = 46, 44.2%), small intestines except terminal ileum (n = 36, 34.6%), colon (n = 29, 27.8%), stomach (n = 6, 5.7%), and perianal (one patient) were the sites of GITB. One-third of all p…

MaleCirrhosismedicine.medical_treatmentretrospective studylaparoscopyColonoscopymultimodal imagingComorbidityGastroenterologyprotionamide0302 clinical medicineLaparotomyAscitesamikacinMedicinebedaquilinePathologie maladies infectieusesintestine biopsyadultsteroidclinical trialGeneral MedicinerifabutinMicrobiologie et protistologie [entomologiephytoparasitolog.]priority journaldiabetes mellitushistopathologybiological productMicrobiology (medical)Microbiologie et protistologie [parasitologie hum. et anim.]medicine.medical_specialtyTuberculosis030106 microbiologymalignant neoplasmArticle03 medical and health scienceslaparotomyHuman immunodeficiency virus infectionmolecular diagnosisHumansTuberculosisGastro-intestinalhumanRetrospective Studiescolondisease predispositionmicrobiologyTuberculosis; Immune-suppression; Gastro-intestinal; Endoscopy;anusmedicine.diseasemajor clinical studymulticenter studyaminosalicylic acidcyclophosphamide0301 basic medicineBiopsyAntitubercular Agentsethambutolrifampicinterminal ileumcolonoscopyofloxacin030212 general & internal medicineLaparoscopyazathioprinemedicine.diagnostic_testIncidence (epidemiology)gastrointestinal tuberculosisDisease Managementchronic kidney failurecycloserineInfectious DiseasesfemaleTreatment OutcomeMolecular Diagnostic Techniquesdiagnostic testDisease Susceptibilitymedicine.symptommoxifloxacinSymptom AssessmentImmune-suppressionstomachisoniazidpyrazinamidestreptomycinliver cirrhosispatient referrallinezolidInternal medicineBiopsybusiness.industryEndoscopyMycobacterium tuberculosishuman tissueclinical featureTreatmentTuberculosis Gastrointestinaltuberculostatic agentbusinessMicrobiologie et protistologie [bacteriol.virolog.mycolog.]
researchProduct

Spasmolytic Effects of Aphanizomenon Flos Aquae (AFA) Extract on the Human Colon Contractility.

2021

The blue-green algae Aphanizomenon flos aquae (AFA), rich in beneficial nutrients, exerts various beneficial effects, acting in different organs including the gut. Klamin® is an AFA extract particularly rich in β-PEA, a trace-amine considered a neuromodulator in the central nervous system. To date, it is not clear if β-PEA exerts a role in the enteric nervous system. The aims of the present study were to investigate the effects induced by Klamin® on the human distal colon mechanical activity, to analyze the mechanism of action, and to verify a β-PEA involvement. The organ bath technique, RT-PCR, and immunohistochemistry (IHC) were used. Klamin® reduced, in a concentration-dependent manner, …

MaleColonmotility discomfortMethysergideGene ExpressionPharmacologyArticle-PEAContractilityTAAR1medicineSerotonin receptor antagonistAphanizomenonHumansTX341-641Myenteric plexusAgedhuman colon contractilityAged 80 and overBiological ProductsAFA extractNutrition and DieteticsDose-Response Relationship DrugChemistryNutrition. Foods and food supplyParasympatholyticsEPPTBMuscle SmoothKlamin®Middle AgedKlamin<sup>®</sup>ImmunohistochemistryMechanism of actionDietary SupplementsEnteric nervous systemFemalePeristalsismedicine.symptomBiomarkersβ-PEAFood Sciencemedicine.drugMuscle ContractionNutrients
researchProduct

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study

2015

Abstract The main guidelines for cardiovascular disease prevention suggest that nutraceuticals could be an efficacious tool to improve lipid pattern. Our aim was to carry out a clinical trial comparing the metabolic effects of a combined nutraceutical containing both red yeast rice and polyunsaturated fatty acids (PUFAs) and a phytosterol-based approach in a setting of clinical practice. This was a multicenter open study with parallel control. We consecutively enrolled 107 pharmacologically untreated subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome, assigned to 8-week treatment with a combined treatment with red yeast rice (Dif1Stat®, including 5 mg monacol…

MaleSettore MED/09 - Medicina InternaMedicine (miscellaneous)PharmacologyTriglycerideDietary supplements; Hypercholesterolemia; Monacolins; Nutraceuticals; Phytosterols; PUFA; Red yeast rice; Medicine (miscellaneous); Nutrition and DieteticsDietary supplementchemistry.chemical_compoundPhytosterolAnticholesteremic AgentMetabolic Syndromechemistry.chemical_classificationMonacolinNutrition and DieteticsAnticholesteremic AgentsPhytosterolPhytosterolsDietary supplements; Hypercholesterolemia; Monacolins; Nutraceuticals; Phytosterols; PUFA; Red yeast rice; Adult; Anticholesteremic Agents; Biological Products; Cholesterol; Cholesterol LDL; Fatty Acids Unsaturated; Female; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Treatment Outcome; Triglycerides; Dietary Supplements; Medicine (miscellaneous); Nutrition and DieteticsLipidMiddle AgedDietary supplementsLipidsCholesterolTreatment OutcomeBiochemistryFatty Acids UnsaturatedBiological ProductFemalelipids (amino acids peptides and proteins)NutraceuticalNutraceuticalsLovastatinFull CommunicationsHumanmedicine.drugPolyunsaturated fatty acidAdultHypercholesterolemiaBiologyNutraceuticalMonacolinsmedicineRed yeast riceHumansLovastatinTriglyceridesBiological ProductsCholesterolCholesterol LDLmedicine.diseaseClinical trialRed yeast ricechemistryMetabolic syndromePUFAJournal of Medicinal Food
researchProduct

Modulation of P450 enzymes by Cuban natural products rich in polyphenolic compounds in rat hepatocytes.

2008

This paper reports cytotoxic effects and changes in the P450 system after exposing rat hepatocytes to four polyphenol-rich products widely used in Cuban traditional medicine (Mangifera indica L. (MSBE), Thalassia testudinum (Tt), Erythroxylum minutifolium and confusum extracts). Effects of mangiferin, the main polyphenol in MSBE, were also evaluated. Cytotoxicity was assayed by the MTT test after exposure of cells to the products (50-1000 microg/mL) for 24 or 72 h. The results showed that 500 microg/mL MSBE was moderately cytotoxic after 72 h, while mangiferin was not. Marked reductions in cell viability were produced by Erythroxylum extracts at concentrationsor = 200 microg/mL, whereas onl…

MaleXanthonesToxicologyRats Sprague-Dawleychemistry.chemical_compoundCytochrome P-450 Enzyme SystemmedicineAnimalsMangiferaMangiferinCells CulturedBiological ProductsMangiferabiologyTraditional medicineMolecular StructureChemistryPlant ExtractsCYP1A2CubaGeneral MedicineCYP2E1biology.organism_classificationErythroxylumRatsPolyphenolPhenacetinChlorzoxazoneHepatocytesMedicine Traditionalmedicine.drugChemico-biological interactions
researchProduct

Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network

2019

Background: Biological therapies have modified the disease course of pediatric inflammatory bowel disease (IBD) and are routinely used in clinical practice. Our observational study aims to evaluate effectiveness and safety of biologics in IBD. Method: Clinical benefit and safety data of 93 children with IBD, receiving biologics (Infliximab – IFX, Adalimumab – ADA, Golimumab – GOL) from January 2013 to December 2017, were extracted from the cohort of the Sicilian Network of IBD. Results: Among 87 children aged 7–17 years (63 Crohn's disease [CD], 24 Ulcerative colitis [UC]), 101 out of 108 biologic treatments were considered. Evaluation of 74 biologic treatments in CD patients at 26, 52, 104…

Malemedicine.medical_specialtyYounger ageAdolescentBiologicEfficacyAnti-Inflammatory AgentsDiseaseInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineCrohn DiseaseGastrointestinal AgentsInternal medicinemedicineHumansAdverse effectChildSicilyRetrospective StudiesBiological ProductsHepatologybusiness.industryGastroenterologyAdalimumabAntibodies MonoclonalBiologics; Child; Efficacy; Inflammatory bowel disease; Safetymedicine.diseaseUlcerative colitisReal life dataInfliximabTreatment Outcome030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyObservational studyColitis UlcerativeFemaleSafetybusiness
researchProduct

Antitumoral compounds from vertebrate sister group: A review of Mediterranean ascidians

2020

Among the diseases that afflict the human population, cancer is one for which many drug treatments are not yet known or effective. Moreover, the pharmacological treatments used often create serious side effects in sick patients and for this reason, it is essential to find effective and less harmful treatments. To date, marine biodiversity is a real source of metabolites with antitumoral activity and among invertebrates' ascidians have been the main source to obtain them. Mediterranean area is the richest in biodiversity and contains several ascidian species used in drugs development during the years. However, many more Mediterranean ascidian species have not been studied and could be a sour…

Mediterranean climateImmunologyPopulationBiodiversitySettore BIO/05 - ZoologiaZoologyAntineoplastic AgentsDrug developmentBiologyPeptides Cyclic01 natural sciencesAntitumoralchemistry.chemical_compoundDepsipeptidesNeoplasmsbiology.animalMediterranean SeaAnimalsHumansUrochordataInvertebrateSettore BIO/06 - Anatomia Comparata E CitologiaeducationCancerBiological Productseducation.field_of_study010405 organic chemistryfungiVertebrateBioactive compound0104 chemical sciencesMarine biodiversity010404 medicinal & biomolecular chemistryDrug developmentchemistrySister groupTunicatesBioactive compoundTrabectedinDevelopmental Biology
researchProduct